GGrantIndex
Sort

326,823 grants matching clinical trial

SPORE in Lung Cancer

$2,579,831
University Of Pittsburgh At Pittsburgh · P50 · FY2002 · CA

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE

$2,579,515
Kathleen Neuzil · University Of Maryland Baltimore · N01 · FY2019 · AI

ECOG Statistical Office Data Management Grant

$2,579,494
Robert J Gray · Frontier Sci & Technology Rsch Fdn, Inc · U10 · FY2006 · CA

University of Washington Vaccine and Treatment Evaluation Unit

$2,579,381
Anna Wald · University Of Washington · UM1 · FY2024 · AI

Immunopathogenesis of Fungal Infections

$2,579,234
Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

$2,579,232
David S Stephens · Emory University · UM1 · FY2023 · AI

The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site

$2,579,213
Charles Drescher · Swedish Medical Center, First Hill · UG1 · FY2022 · CA

Univ.of Calif., Irvine Cancer Center Support Grant

$2,578,854
University Of California Irvine · P30 · FY2005 · CA

Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses

$2,578,594
James E Crowe · University Of Texas Med Br Galveston · U19 · FY2021 · AI

Discovery and validation of novel targets for pharmacotherapy of alcoholism

$2,578,533
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2009 · AA

Rutgers University CounterACT Center of Excellence

$2,578,396
Jeffrey D Laskin · Rbhs-School Of Public Health · U54 · FY2021 · AR

Molecular and Cellular Determinants of Disease Heterogeneity in COPD

$2,578,270
Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · HL

Skeletal Disorders and Mineral Homeostasis Section

$2,578,134
Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE

Novel Therapies of Chronic Allograft Dysfunction

$2,578,092
Brigham And Women'S Hospital · U01 · FY2004 · AI

Cell and Gene Therapy for Nonmalignant Blood Disorders

$2,578,045
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2017 · HL

THE IMPACTA PERU CLINICAL TRIALS UNIT

$2,577,705
Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · U01 · FY2007 · AI

Immune Cell Interactions in Atherosclerosis

$2,577,670
Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2019 · HL

Immune Cell Interactions in Atherosclerosis

$2,577,670
Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2021 · HL

Immune Cell Interactions in Atherosclerosis

$2,577,670
Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2020 · HL

The Lung Transplant Clinical Trials Network (LT-CTN)

$2,577,651
Scott M Palmer · Duke University · U01 · FY2017 · AI

The Lung Transplant Clinical Trials Network (LT-CTN)

$2,577,651
Scott M Palmer · Duke University · U01 · FY2016 · AI

The Lung Transplant Clinical Trials Network (LT-CTN)

$2,577,651
Scott M Palmer · Duke University · U01 · FY2015 · AI

Vanderbilt HIV Clinical Trials Unit (CTU)

$2,577,612
David W Haas · Vanderbilt University Medical Center · UM1 · FY2021 · AI

Menopausal Symptoms Initiative-Finding Lasting Answers for Sweats and Hot Flashes

$2,577,565
Andrea Z. Lacroix · Fred Hutchinson Cancer Research Center · U01 · FY2011 · AG

Immune Cell Interactions in Atherosclerosis

$2,577,497
Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2018 · HL